Schedule 13G ownership disclosure

ProQR Therapeutics NV

Ordinary Shares, nominal value 0.04 euro per share · CUSIP: N71542109

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Adage Capital Management, L.P.

    Shares: 8,102,098.00 · Class: 7.70%

  • Robert Atchinson

    Shares: 8,102,098.00 · Class: 7.70%

  • Phillip Gross

    Shares: 8,102,098.00 · Class: 7.70%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002247
Form type
SCHEDULE 13G/A
Filer
Adage Capital Management, L.P.
CIK
CIK 1535978
Filed
May 12, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub